An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 020572
Company: HORIZON THERAP US

Products on NDA 020572

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
BUPHENYL	SODIUM PHENYLBUTYRATE	500MG	TABLET;ORAL	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 020572

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
05/13/1996	ORIG-1	Approval	Type 3 - New Dosage Form	PRIORITY; Orphan		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/29/2022	SUPPL-25	Labeling-Patient Package Insert, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020572s025,020573s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/020572Orig1s025,020573Orig1s022ltr.pdf
10/06/2015	SUPPL-21	Manufacturing (CMC)		Label is not available on this site.
08/02/2013	SUPPL-20	Manufacturing (CMC)		Label is not available on this site.
03/31/2009	SUPPL-16	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020572s016,020573s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020572s016,020573s015ltr.pdf
10/09/1998	SUPPL-2	Labeling		Label is not available on this site.
11/07/1996	SUPPL-1	Manufacturing (CMC)-Control		Label is not available on this site.

Labels for NDA 020572

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/29/2022	SUPPL-25	Labeling-Patient Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020572s025,020573s022lbl.pdf
07/29/2022	SUPPL-25	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020572s025,020573s022lbl.pdf
03/31/2009	SUPPL-16	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020572s016,020573s015lbl.pdf

Therapeutic Equivalents for NDA 020572

BUPHENYL

TABLET;ORAL; 500MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
BUPHENYL	SODIUM PHENYLBUTYRATE	500MG	TABLET;ORAL	Prescription	Yes	AB	020572	HORIZON THERAP US
SODIUM PHENYLBUTYRATE	SODIUM PHENYLBUTYRATE	500MG	TABLET;ORAL	Prescription	No	AB	216462	GLENMARK PHARMS LTD
SODIUM PHENYLBUTYRATE	SODIUM PHENYLBUTYRATE	500MG	TABLET;ORAL	Prescription	No	AB	204395	PAR PHARM

Top